<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="//www.berentx.com/wp-content/plugins/wordpress-seo/css/main-sitemap.xsl"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-image/1.1 http://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
	<url>
		<loc>https://www.berentx.com/news/npc-community-update-september-2021/</loc>
		<lastmod>2021-09-01T04:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.berentx.com/news/npc-expanded-access-program-continues-september-2021/</loc>
		<lastmod>2021-09-16T04:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.berentx.com/news/npc-community-update-october-2021/</loc>
		<lastmod>2021-10-01T04:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.berentx.com/news/npc-community-update-november-2021/</loc>
		<lastmod>2021-11-01T04:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.berentx.com/news/npc-community-update-december-2021/</loc>
		<lastmod>2021-12-01T05:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.berentx.com/news/npc-community-update-january-2022/</loc>
		<lastmod>2022-01-01T05:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.berentx.com/news/npc-community-update-february-2022/</loc>
		<lastmod>2022-02-01T05:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.berentx.com/news/npc-community-update-may-2022/</loc>
		<lastmod>2022-05-01T04:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.berentx.com/news/npc-community-update-november-2022/</loc>
		<lastmod>2022-11-01T04:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.berentx.com/news/roquette-strategic-investment-mandos-health-npc/</loc>
		<lastmod>2023-05-23T04:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.berentx.com/news/npc-community-update-june-2023/</loc>
		<lastmod>2023-06-01T04:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.berentx.com/news/npc-community-update-february-2024/</loc>
		<lastmod>2024-02-01T05:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.berentx.com/news/npc-community-update-september-2024/</loc>
		<lastmod>2024-09-01T04:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.berentx.com/news/npc-community-update-october-2024/</loc>
		<lastmod>2024-10-01T04:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.berentx.com/news/npc-community-update-february-2025/</loc>
		<lastmod>2025-02-01T05:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.berentx.com/news/npc-community-update-may-2025/</loc>
		<lastmod>2025-05-01T04:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.berentx.com/news/mandos-health-new-analyses-npc-september-2025/</loc>
		<lastmod>2025-09-12T04:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.berentx.com/news/npc-community-update-october-2025/</loc>
		<lastmod>2025-10-01T04:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.berentx.com/news/adrabetadex-data-analyses-show-benefit-npc/</loc>
		<lastmod>2025-10-09T04:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.berentx.com/news/adrabetadex-receives-breakthrough-designation-by-fda/</loc>
		<lastmod>2025-12-09T05:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.berentx.com/news/adrabetadex-nda-submitted-npc/</loc>
		<lastmod>2025-12-19T05:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.berentx.com/news/adrabetadex-new-drug-application-fda-filing-december-2025/</loc>
		<lastmod>2025-12-19T05:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.berentx.com/news/npc-webinar-highlights-path-forward-february-2026/</loc>
		<lastmod>2026-02-01T05:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.berentx.com/news/adrabetadex-nda-accepted-priority-review-npc/</loc>
		<lastmod>2026-02-23T05:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.berentx.com/news/beren-therapeutics-presents-data-supporting-the-efficacy-of-adrabetadex-in-infantile-onset-npc-at-2026-acmg-clinical-genetics-meeting/</loc>
		<lastmod>2026-03-12T04:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.berentx.com/news/beren-therapeutics-announces-fda-extension/</loc>
		<lastmod>2026-05-28T04:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.berentx.com/news/presentations-at-the-2026-ara-parseghian-medical-research-fund-conference/</loc>
		<lastmod>2026-05-29T04:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.berentx.com/news/beren-secures-300m-financing-to-support-the-potential-commercial-launch-of-adrabetadex/</loc>
		<lastmod>2026-06-10T04:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.berentx.com/news/community-update-building-long-term-support-for-families/</loc>
		<lastmod>2026-06-10T04:00:00+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.berentx.com/news/beren-therapeutics-expands-cyclodextrin-intellectual-property-estate-with-eight-new-u-s-issued-patents/</loc>
		<lastmod>2026-11-10T14:58:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.berentx.com/news/beren-therapeutics-presents-new-adrabetadex-data-showing-preservation-of-neurological-function-for-more-than-10-years-in-children-with-infantile-onset-npc/</loc>
		<lastmod>2026-11-10T15:31:04+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.berentx.com/news/beren-therapeutics-launches-test-for-npc-to-help-identify-people-with-niemann-pick-disease-type-c-who-remain-undiagnosed/</loc>
		<lastmod>2026-11-10T15:33:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.berentx.com/news/community-update-recognizing-niemann-pick-awareness-month/</loc>
		<lastmod>2026-11-10T15:35:27+00:00</lastmod>
	</url>
</urlset>
<!-- XML Sitemap generated by Yoast SEO -->